Full Text View
Tabular View
No Study Results Posted
Related Studies
Paroxetine-Referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD
This study has been completed.
Study NCT00445679   Information provided by Wyeth is now a wholly owned subsidiary of Pfizer

First Received on March 6, 2007.   Last Updated on July 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Depressive Disorder, Major
Additional conditions recognized in this trial
Depression
Depressive Disorder
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
DVS-233 SR
Paroxetine
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Wyeth is now a wholly owned subsidiary of Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services